Homing Pathways of Mesenchymal Stromal Cells (MSCs) and Their Role in Clinical Applications

REFERENCES

• Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976; 4: 267–274.
   PubMed Web of Science ®Google Scholar
• Horwitz EM, Le Blanc K, Dominici M, Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005; 7: 393–395.
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315–317.
   PubMed Web of Science ®Google Scholar
• Karp JM, Leng Teo GS. Mesenchymal stem cell homing: The devil is in the details. Cell Stem Cell 2009; 4: 206–216.
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, (1999). Multilineage potential of adult mesenchymal stem cells. Science 1999; 284: 143–147.
   PubMed Web of Science ®Google Scholar
• Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: Revisiting history, concepts, and assays. Cell Stem Cell 2008; 2: 313–319.
   PubMed Web of Science ®Google Scholar
• da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006; 119: 2204–2213.
   PubMed Web of Science ®Google Scholar
• da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 2008; 26: 2287–2299.
   PubMed Web of Science ®Google Scholar
• Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007; 110: 3499–3506.
   PubMed Web of Science ®Google Scholar
• Springer T. 1994. Traffic signals for lymphocyte recirculation and leucocyte emigration: The multistep paradigm. Cell 1994; 76: 301–314.
   PubMed Web of Science ®Google Scholar
• Gao J, Dennis JE, Muzic RF, The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tiss Organs 2001; 169: 12–20.
   PubMed Web of Science ®Google Scholar
• Devine SM, Cobbs C, Jennings M, Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 2003; 101: 2999–3001.
   PubMed Web of Science ®Google Scholar
• Bensidhoum M, Chapel A, Francois S, Homing of in vitro expanded Stro-1–or Stro-1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment. Blood 2004; 103: 3313–3319.
   PubMedGoogle Scholar
• Lee RH, Pulin AA, Seo MJ, Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009; 5: 54–63.
   PubMed Web of Science ®Google Scholar
• Anjos-Afonso F, Siapati EK, Bonnet D. In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J Cell Sci 2004; 117: 5655–5664. doi:10.1242/jcs.01488.
   PubMed Web of Science ®Google Scholar
• Deak E, Rüster B, Keller L, (2010) Suspension medium influences interaction of mesenchymal stromal cells with endothelium and pulmonary toxicity after transplantation in mice. Cytotherapy 2010; 12: 260–264.
   Web of Science ®Google Scholar
• Ortiz LA, Gambelli F, McBride C, Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A 2003; 100: 8407–8411.
   PubMed Web of Science ®Google Scholar
• Koç ON, Gerson SL, Cooper BW, Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000; 18: 307–316.
   PubMed Web of Science ®Google Scholar
• Macmillan ML, Blazar BR, DeFor TE, Wagner JE. Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: Results of a phase I–II clinical trial. Bone Marrow Trans 2009; 43: 447–454.
   PubMed Web of Science ®Google Scholar
• Lazarus HM, Koc ON, Devine SM, Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Trans 2005; 11: 389–398.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Samuelsson H, Gustafsson B, Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia. 2007; 21: 1733–1738.
   Google Scholar
• Rombouts WJ, Ploemacher RE. Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia 2003; 17: 160–170.
   PubMed Web of Science ®Google Scholar
• Ball LM, Bernardo ME, Roelofs H, Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood 2007; 110: 2764–2767.
   PubMed Web of Science ®Google Scholar
• Kim DW, Chung YJ, Kim TG, Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation. Blood 2004; 103: 1941–1948.
   PubMed Web of Science ®Google Scholar
• Maitra B, Szekely E, Gjini K, Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Trans 2004; 33: 597–604.
   PubMed Web of Science ®Google Scholar
• Sensebé L, Krampera M, Schrezenmeier H, Mesenchymal stem cells for clinical application. Vox Sang 2010; 98: 93–107.
   PubMed Web of Science ®Google Scholar
• Cilloni D, Carlo-Stella C, Falzetti F, Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation. Blood 2000; 96: 3637–3643.
   PubMed Web of Science ®Google Scholar
• Goan SR, Junghahn I, Wissler M, Donor stromal cells from human blood engraft in NOD/SCID mice. Blood 2000; 96: 3971–3978.
   PubMed Web of Science ®Google Scholar
• Erices AA, Allers CI, Conget PA, Human cord blood-derived mesenchymal stem cells home and survive in the marrow of immunodeficient mice after systemic infusion. Cell Transplant 2003; 12: 555–561.
   PubMed Web of Science ®Google Scholar
• Wynn RF, Hart CA, Corradi-Perini C, A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 2004; 104: 2643–2645.
   PubMed Web of Science ®Google Scholar
• Sackstein R, Merzaban JS, Cain DW, Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med 2008; 14: 181–187.
   PubMed Web of Science ®Google Scholar
• Méndez-Ferrer S, Frenette PS. Galpha(s) uncouples hematopoietic stem cell homing and mobilization. Cell Stem Cell 2009; 4: 379–380.
   Google Scholar
• Horwitz EM, Gordon PL, Koo WK, Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A 2002; 99: 8932–8937.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Götherström C, Ringdén O, Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 2005; 79: 1607–1614.
   PubMed Web of Science ®Google Scholar
• Pereira RF, O’Hara MD, Laptev AV, Marrow stomal cells as a source of progenitor cells for nonhemtapoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci U S A 1998; 95: 1142–1147.
   PubMed Web of Science ®Google Scholar
• Marino R, Martinez C, Boyd K, Transplantable marrow osteoprogenitors engraft in discrete saturable sites in the marrow microenvironment. Exp Hematol 2008; 36: 360–368.
   PubMed Web of Science ®Google Scholar
• Noël D, Djouad F, Bouffi C, Multipotent mesenchymal stromal cells and immune tolerance. Leuk Lymphoma 2007; 48: 1283–1289.
   PubMed Web of Science ®Google Scholar
• Sato K, Ozaki K, Oh I, Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 2007; 109: 228–234.
   PubMed Web of Science ®Google Scholar
• Casiraghi F, Azzollini N, Cassis P, Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells 1. J Immunol 2008; 181: 3933–3946.
   PubMed Web of Science ®Google Scholar
• Ruster B, Gottig S, Ludwig RJ, Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood 2006; 108: 3938– 3944.
   PubMed Web of Science ®Google Scholar
• Shi M, Li J, Liao L, Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: Role in homing efficiency in NOD/SCID mice. Haematologica 2007; 92: 897–904.
   PubMed Web of Science ®Google Scholar
• Ren G, Zhang L, Zhao X, Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2008; 2: 141–150.
   PubMed Web of Science ®Google Scholar
• Wu GD, Nolta JA, Jin YS, Migration of mesenchymal stem cells to heart allografts during chronic rejection. Transplantation 2003; 75: 679–685.
   PubMedGoogle Scholar
• Förster R, Davalos-Misslitz AC, Rot A. CCR7 and its ligands: Balancing immunity and tolerance. Nat Rev Immunol. 2008; 5: 362–371.
   Google Scholar
• Gonzalo-Daganzo R, Regidor C, Martín-Donaire T, Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults. Cytotherapy 2009; 11: 278–288.
   Web of Science ®Google Scholar
• Tyndall A, Uccelli A. Multipotent mesenchymal stromal cells for autoimmune diseases: Teaching new dogs old tricks. Bone Marrow Trans 2009; 43: 821–828.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Shi S, Liu Y, Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J Immunol 2009; 183: 7787–7798.
   PubMed Web of Science ®Google Scholar
• Rafei M, Campeau PM, Aguilar-Mahecha A, Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner.J Immunol. 2009; 182: 5994–6002.
   PubMed Web of Science ®Google Scholar
• Németh K, Leelahavanichkul A, Yuen PS, Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009; 15: 42–49.
   PubMed Web of Science ®Google Scholar
• Romieu-Mourez R, François M, Boivin MN, Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype. J Immunol 2009; 182: 7963–7973.
   PubMed Web of Science ®Google Scholar
• Kraitchman DL, Tatsumi M, Gilson WD, Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 2005; 112: 1451–1461.
   PubMed Web of Science ®Google Scholar
• Freyman T, Polin G, Osman H, A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 2006; 27: 1114–1122.
   PubMed Web of Science ®Google Scholar
• Martens TP, See F, Schuster MD, Mesenchymal lineage precursor cells induce vascular network formation in ischemic myocardium. Nat Clin Pract Cardiovasc Med 2006; 3: S18–S22.
   PubMedGoogle Scholar
• Segers VFM, Van Riet I, Andries LJ, Mesenchymal stem cell adhesion to cardiac microvascular endothelium: Activators and mechanisms. Am J Physiol Heart Circ Physiol 2006; 290: H1370–H1377.
   PubMed Web of Science ®Google Scholar
• Ip JE, Wu Y, Huang J, Mesenchymal stem cells use integrin b1 not CXC chemokine receptor 4 for myocardial migration and engraftment. Mol Biol Cell 2007; 18: 2873–2882.
   PubMed Web of Science ®Google Scholar
• Schenk S, Mal N, Finan A, Monocyte chemotactic protein-3 is a myocardial MSC homing factor. Stem Cells 2007; 25: 245–251.
   PubMed Web of Science ®Google Scholar
• Belema-Bedada F, Uchida S, Martire A, Efficient homing of multipotent adult MSCs depends on FROUNT-mediated clustering of CCR2. Cell Stem Cell 2008; 2: 566–575.
   PubMed Web of Science ®Google Scholar
• Cheng Z, Ou L, Zhou X, Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther 2008; 16: 571–579.
   PubMed Web of Science ®Google Scholar
• Haider HKH, Jiang S, Idris NM, Ashraf M. IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circ Res 2008; 103: 1300–1308.
   PubMed Web of Science ®Google Scholar
• Wagner DD, Frenette PS. The vessel wall and its interactions. Blood 2008; 111: 5271–5281.
   PubMed Web of Science ®Google Scholar
• Satoh H, Kishi K, Tanaka T, Transplanted mesenchymal stem cells are effective for skin regeneration in acute cutaneous wounds. Cell Trans 2004; 13: 405–412.
   PubMed Web of Science ®Google Scholar
• Falanga V, Iwamoto S, Chartier M, Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng 2007; 13: 1299–1312.
   PubMedGoogle Scholar
• Sasaki M, Abe R, Fujita Y, Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol 2008; 180: 2581–2587.
   PubMed Web of Science ®Google Scholar
• Zhang J, Gong JF, Zhang W, Effects of transplanted bone marrow mesenchymal stem cells on the irradiated intestine of mice. J Biomed Sci 2008; 15: 585–594.
   PubMedGoogle Scholar
• Sordi V, Malosio ML, Marchesi F, Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 2005; 106: 419–427.
   PubMed Web of Science ®Google Scholar
• Fiorina P, Jurewicz M, Augello A, Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol 2009; 183: 993–1004.
   PubMed Web of Science ®Google Scholar
• Kunter U, Rong S, Djuric Z, Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol 2006; 17: 2202–2212.
   PubMed Web of Science ®Google Scholar
• Herrera MB, Bussolati B, Bruno S, Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Intl 2007; 72: 430–441.
   PubMed Web of Science ®Google Scholar
• Morigi M, Rota C, Montemurro T, Life-sparing effect of human cord-blood mesenchymal stem cells in experimental acute kidney injury. Stem Cells. Retrieved 4 Jan 2010.
   Google Scholar
• Dwyer RM, Potter-Beirne SM, Harrington KA, Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin Cancer Res 2007; 13: 5020–5027.
   PubMed Web of Science ®Google Scholar
• Karnoub AE, Dash AB, Vo AP, Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature. 2007; 449: 557–563.
   PubMed Web of Science ®Google Scholar
• Breitbach M, Bostani T, Roell W, Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 2007; 110: 1362–1369.
   PubMed Web of Science ®Google Scholar
• Hsiao JK, Tai MF, Chu HH, Magnetic nanoparticle labeling of mesenchymal stem cells without transfection agent: Cellular behavior and capability of detection with clinical 1.5 T magnetic resonance at the single cell level. Magn Reson Med 2007; 58: 717–724.
   PubMedGoogle Scholar
• Walczak P, Zhang J, Gilad AA. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 2008; 39: 1569–1574.
   PubMed Web of Science ®Google Scholar
• Annabi B, Lee Y-T, Turcotte S, Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation. Stem Cells 2003; 21: 337–347.
   PubMed Web of Science ®Google Scholar
• De Becker A, Van Hummelen P, Bakkus M, Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3. Haematologica 2007; 92: 440–449.
   PubMed Web of Science ®Google Scholar
• Ries C, Egea V, Karow M, MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: Differential regulation by inflammatory cytokines. Blood 2007; 109: 4055–4063.
   PubMed Web of Science ®Google Scholar